Home
NewsNewsLG Chem’s App for Infertility and Pregnancy Preparation, Bloom, brings together fertility education, treatment explanations, emotional support, and preparation tools in one digital platform. Designed as a companion rather than a clinical service, the app addresses growing information gaps faced by individuals and couples navigating infertility and pregnancy preparation.
Infertility has become a significant concern in modern society, with delayed marriages, environmental factors, and lifestyle changes contributing to increased fertility challenges. As more individuals and couples seek support during pregnancy preparation, digital healthcare tools are emerging to bridge the information gap. One such platform is the Bloom app for infertility and pregnancy preparation, developed by LG Chem in collaboration with leading reproductive medicine organizations in Korea.
Unveiled in September 2025, Bloom isn’t just another health app. It is a digital healthcare platform designed to give people scientifically grounded guidance on fertility, infertility, and preparing the body and mind for pregnancy. LG Chem positioned Bloom as a companion for women aiming to conceive, couples facing difficulties conceiving, and individuals looking toward future fertility preservation. The app’s name carries metaphorical weight: a blend of new life, hope, and the full bloom of possibility.
Infertility is no longer a fringe issue. Demographic shifts, like later marriages and changing lifestyles, mean that increasing numbers of couples confront conception challenges. But beyond statistics, the emotional landscape can be heavy: confusion, countless online searches, and uncertainty about what steps to take next. LG Chem’s internal research suggested that while information exists, it’s scattered, technical, and often hard for laypeople to parse. Bloom aims to centralize that information and make it usable.
The Bloom app for infertility and pregnancy preparation includes several informational and support components:
A few months after its release, Bloom gained industry validation. In December 2025, the app won the grand prize in the medical service category at the Smart App Awards, one of Korea’s respected tech recognitions, judged by a 4,000-member panel assessing design, user interface, content quality, and technological innovation.
The award citation emphasized Bloom’s scientific approach to supporting both infertility and pregnancy preparation, acknowledging that these are not purely personal concerns but broader public health issues. Such recognition suggests that the app’s design aligns with real-world needs, not just corporate ambition.
While the Bloom app for infertility and pregnancy preparation serves as a comprehensive information resource, it functions as a supplementary tool to professional medical consultation. The app provides educational content and practical guidance but does not replace individualized medical advice from fertility specialists or reproductive endocrinologists.
The Bloom app for infertility and pregnancy preparation represents an effort to consolidate infertility-related information, emotional support resources, and practical preparation materials into a single digital platform. By providing expert-verified content and community features, the Bloom app for infertility and pregnancy preparation addresses some of the informational and emotional needs individuals and couples face during pregnancy preparation and infertility treatment journeys.
The Stork Foundation for Infertility received a record 1,076 grant applications in 2026, with data revealing that 85% of applicants have no fertility treatment coverage for the care they are pursuing. Average anticipated next treatment costs stand at 19,149 USD, with 39% having already spent more than 10,000 USD out of pocket.
Future Health, A Global Initiative by Abu Dhabi has launched the Future Health Digital Health Innovation Challenge 2026, inviting global innovators to develop AI, software, and connected technology solutions across fertility, population health, and well-being. Three finalists will share USD 105,000 at GITEX 2026, with selected solutions eligible for incubation and scale.
La Trobe University and GonGlobal have entered a strategic collaboration to develop and validate AI and digital twin technologies for ART and IVF. The partnership will build AI-driven fertility care tools, including cohort matching digital twins and deep-learning models, to predict pregnancy outcomes and support personalised clinical decision-making.
IVI Institute has announced the acquisition of The World Egg and Sperm Bank (TWESB), founded in 2004 and operating from Scottsdale, Arizona. The move expands access to reproductive solutions for patients and clinics across the United States and Australia, combining TWESB’s network of 500+ screened donors with IVI Institute’s global clinical and scientific infrastructure.
Doctors at NHS Lothian in Edinburgh have performed the UK’s first testicular tissue transplant, reimplanting tissue frozen before chemotherapy in a 19-year-old patient with a serious blood disorder. The testicular tissue transplant, only the second reported worldwide, could eventually give thousands of young boys a realistic path to future fatherhood.
Flora Fertility and Clue have announced the Flora Clue fertility partnership, connecting the first individually owned fertility insurance platform with the world’s leading women-led cycle tracking app. FLORA policyholders receive complimentary Clue Plus access, while Clue’s community of over 100 million members gains early exposure to proactive fertility financial planning.
The World Health Organization releases its first comprehensive, evidence-based global guideline for infertility prevention, diagnosis, and treatment. Addressing one in six people of reproductive age worldwide, the guideline emphasizes equity, human rights, and standardized interventions to improve access to fertility care globally.
